PGLYRP3/PGRPIA Antibodies
We offer PGLYRP3/PGRPIA Antibodies for use in common research applications: Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot. Each PGLYRP3/PGRPIA Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our PGLYRP3/PGRPIA Antibodies can be used in a variety of model species: Human. Use the list below to choose the PGLYRP3/PGRPIA Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our PGLYRP3/PGRPIA polyclonal antibodies and browse our PGLYRP3/PGRPIA monoclonal antibody catalog.
Alternate Names for PGLYRP3/PGRPIA Antibodies
anti-PGLYRP3/PGRPIA antibody, anti-PGLYRP3 antibody, anti-peptidoglycan recognition protein 3 antibody, anti-peptidoglycan recognition protein I alpha antibody, anti-Peptidoglycan recognition protein I-alpha antibody, anti-Peptidoglycan recognition protein intermediate alpha antibody, anti-peptidoglycan recognition protein-I-alpha antibody, anti-PGLYRPIalphaMGC149197 antibody, anti-PGRP-Ialpha antibody, anti-PGRPIAPGRP-I-alpha antibody
2 Results for "pglyrp3-pgrpia" in Primary Antibodies
![Western Blot: PGLYRP3/PGRPIA Antibody (187C434) [NB100-56729] - Analysis in cell lysates from human brain using this antibody at a dilution of 1:500.](http://images.novusbio.com/fullsize/PGLYRP3-PGRPIA-Antibody-187C434-Western-Blot-NB100-56729-img0005.jpg "Western Blot: PGLYRP3/PGRPIA Antibody (187C434) [NB100-56729] - Analysis in cell lysates from human brain using this antibody at a dilution of 1:500.")
![Immunocytochemistry/Immunofluorescence: PGLYRP3/PGRPIA Antibody (187C434) [NB100-56729] - A. HCECs were exposed to HKCA (106 cells/ml) with prior incubation in the absence or presence of isotype IgG (10ug/ml), dectin-1 neutralizing Ab (10ug/ml), BAY11-7082 (10uM) or NF-kB activation inhibitor quinazoline (NF-kB-I, 10uM) for 1 h. HCECs were treated with 106 cells/ml HKCA for 48 hours in 8-chamber slides and examined by immunofluorescent staining for PGLYRPs 3 and 4. (NB100-56721) C. The percentages of positive cells of PGLYRPs 3 and 4 staining in HCECs in A was quantified. Results shown are the mean +/- SD of four independent experiments; *** p<0.001, as compared with normal control; ^^ p<0.005, ^^^ p<0.001, as compared with HCECs exposed to HKCA. Magnification: 400x (bar = 25um). Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0128039) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PGLYRP3-PGRPIA-Antibody-187C434-Immunocytochemistry-Immunofluorescence-NB100-56729-img0006.jpg)
![Western Blot: PGLYRP3/PGRPIA Antibody [NBP2-85468] - WB Suggested Anti-PGLYRP3 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Heart](http://images.novusbio.com/fullsize/PGLYRP3-PGRPIA-Antibody-Western-Blot-NBP2-85468-img0001.jpg "Western Blot: PGLYRP3/PGRPIA Antibody [NBP2-85468] - WB Suggested Anti-PGLYRP3 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Heart")